17332506 | The NHERF1 PDZ2 domain regulates PKA-RhoA-p38-mediated NHE1 activation and invasion in breast tumor cells. | Mol Biol Cell | 2007 May | Cardone RA | - |
22622406 | The detection of EBP50 expression using quantum dot immunohistochemistry in pancreatic cancer tissue and down-regulated EBP50 effect on PC-2 cells. | J Mol Histol | 2012 Oct | Ji MY | doi: 10.1007/s10735-012-9424-0 |
25756512 | PTEN inhibits macrophage polarization from M1 to M2 through CCL2 and VEGF-A reduction and NHERF-1 synergism. | Cancer Biol Ther | 2015 | Li N | doi: 10.1080/15384047.2014.1002353. |
15467753 | NHERF (Na+/H+ exchanger regulatory factor) gene mutations in human breast cancer. | Oncogene | 2004 Nov 11 | Dai JL | - |
20736378 | Loss of PTEN binding adapter protein NHERF1 from plasma membrane in glioblastoma contributes to PTEN inactivation. | Cancer Res | 2010 Sep 1 | Molina JR | doi: 10.1158/0008-5472.CAN-10-1271 |
21804599 | PTEN, NHERF1 and PHLPP form a tumor suppressor network that is disabled in glioblastoma. | Oncogene | 2012 Mar 8 | Molina JR | doi: 10.1038/onc.2011.324 |
21822312 | Loss of EBP50 stimulates EGFR activity to induce EMT phenotypic features in biliary cancer cells. | Oncogene | 2012 Mar 15 | Clap??ron A | doi: 10.1038/onc.2011.334 |
22476347 | EBP50 inhibits EGF-induced breast cancer cell proliferation by blocking EGFR phosphorylation. | Amino Acids | 2012 Nov | Yao W | doi: 10.1007/s00726-012-1277-z |
21707710 | Na+/H+ exchanger regulatory factor 1 expression levels in blood and tissue predict breast tumour clinical behaviour. | Histopathology | 2011 Jun | Bellizzi A | doi: 10.1111/j.1365-2559.2011.03844.x. |
28739728 | Ezrin-Radixin-Moesin Binding Phosphoprotein 50 (EBP50) Suppresses the Metastasis of Breast Cancer and HeLa Cells by Inhibiting Matrix Metalloproteinase-2 Activity. | Anticancer Res | 2017 Aug | Wang L | - |
29551770 | β-catenin knockdown promotes NHERF1-mediated survival of colorectal cancer cells: implications for a double-targeted therapy. | Oncogene | 2018 Jun | Saponaro C | doi: 10.1038/s41388-018-0170-y |
20012548 | EBP50 exerts tumor suppressor activity by promoting cell apoptosis and retarding extracellular signal-regulated kinase activity. | Amino Acids | 2010 Apr | Zheng JF | doi: 10.1007/s00726-009-0437-2 |
24201803 | Nuclear NHERF1 expression as a prognostic marker in breast cancer. | Cell Death Dis | 2013 Nov 7 | Paradiso A | doi: 10.1038/cddis.2013.439. |
24012959 | Breast cancer-derived K172N, D301V mutations abolish Na+/H+ exchanger regulatory factor 1 inhibition of platelet-derived growth factor receptor signaling. | FEBS Lett | 2013 Oct 11 | Cheng S | doi: 10.1016/j.febslet.2013.08.026 |
22366766 | EBP50 gene transfection promotes 5-fluorouracil-induced apoptosis in gastric cancer cells through Bax- and Bcl-2-triggered mitochondrial pathways. | Mol Med Rep | 2012 May | Lv XG | doi: 10.3892/mmr.2012.805 |
26126066 | The potential predictive role of nuclear NHERF1 expression in advanced gastric cancer patients treated with epirubicin/oxaliplatin/capecitabine first line chemotherapy. | Cancer Biol Ther | 2015 | Mangia A | doi: 10.1080/15384047.2015.1056414 |
26218645 | SLC9A3R1 stimulates autophagy via BECN1 stabilization in breast cancer cells. | Autophagy | 2015 | Liu H | doi: 10.1080/15548627.2015.1074372. |
22440733 | Overexpression of nuclear NHERF1 in advanced colorectal cancer: association with hypoxic microenvironment and tumor invasive phenotype. | Exp Mol Pathol | 2012 Jun | Malfettone A | doi: 10.1016/j.yexmp.2012.03.004 |
12830000 | EBP50, a beta-catenin-associating protein, enhances Wnt signaling and is over-expressed in hepatocellular carcinoma. | Hepatology | 2003 Jul | Shibata T | - |
21496870 | Human epidermal growth factor receptor 2, Na+/H+ exchanger regulatory factor 1, and breast cancer susceptibility gene-1 as new biomarkers for familial breast cancers. | Hum Pathol | 2011 Nov | Mangia A | doi: 10.1016/j.humpath.2011.01.010 |
21170265 | NHERF1/EBP50 is a new marker in colorectal cancer. | Neoplasia | 2010 Dec | Hayashi Y | - |
17593079 | Expression and clinicopathological significance of oestrogen-responsive ezrin-radixin-moesin-binding phosphoprotein 50 in breast cancer. | Histopathology | 2007 Jul | Song J | - |
26977012 | A Novel NHERF1 Mutation in Human Breast Cancer Inactivates Inhibition by NHERF1 Protein in EGFR Signaling. | Anticancer Res | 2016 Mar | DU G | - |
27823775 | Similar expression pattern of NHERF1 and EZRIN in papillary but not in solid areas of human serous ovarian carcinomas. | Acta Histochem | 2016 Oct | Demacopulo B | doi: 10.1016/j.acthis.2016.10.002 |
28011475 | A Novel NHERF1 Mutation in Human Breast Cancer and Effects on Malignant Progression. | Anticancer Res | 2017 Jan | Yang X | - |
27509846 | EBP50 interacts with EGFR and regulates EGFR signaling to affect the prognosis of cervical cancer patients. | Int J Oncol | 2016 Oct | Peng Z | doi: 10.3892/ijo.2016.3655 |
28739734 | NHERF1 Suppresses Lung Cancer Cell Migration by Regulation of Epithelial-Mesenchymal Transition. | Anticancer Res | 2017 Aug | Yang F | - |
28068322 | Role of the PDZ-scaffold protein NHERF1/EBP50 in cancer biology: from signaling regulation to clinical relevance. | Oncogene | 2017 Jun 1 | Vaquero J | doi: 10.1038/onc.2016.462 |
27097111 | The cellular distribution of Na+/H+ exchanger regulatory factor 1 is determined by the PDZ-I domain and regulates the malignant progression of breast cancer. | Oncotarget | 2016 May 17 | Du G | doi: 10.18632/oncotarget.8751. |
27448983 | NHERF1, a novel GPER associated protein, increases stability and activation of GPER in ER-positive breast cancer. | Oncotarget | 2016 Aug 23 | Meng R | doi: 10.18632/oncotarget.10713. |
27999191 | NHERF1 regulates the progression of colorectal cancer through the interplay with VEGFR2 pathway. | Oncotarget | 2017 Jan 31 | Gu Y | doi: 10.18632/oncotarget.13949. |
28684865 | Dynamic relocalization of NHERF1 mediates chemotactic migration of ovarian cancer cells toward lysophosphatidic acid stimulation. | Exp Mol Med | 2017 Jul 7 | Oh YS | doi: 10.1038/emm.2017.88. |
28535016 | NHERF1 inhibits proliferation of triple-negative breast cancer cells by suppressing GPER signaling. | Oncol Rep | 2017 Jul | Wang Y | doi: 10.3892/or.2017.5649 |
29901158 | Wnt signaling pathway upregulates DNMT1 to trigger NHERF1 promoter hypermethylation in colon cancer. | Oncol Rep | 2018 Aug | Guo Y | doi: 10.3892/or.2018.6494 |